Navigation Links
Activated T-Cells Could Help In The Battle Against HIV

Researchers have explained that on altering the immune cells and incorporating it into the vaccine they could develop a therapeutic treatment for AIDS. //

Researchers from the University of Pittsburgh have claimed that they are of the belief that if patients with HIV, subject their immune system cells through a laboratory version of boot camp, it could help in their fight against the disease. Announcing their findings at the AIDS 2006 conference in Toronto, yesterday they explained that this would be in core concept for developing a novel therapeutic vaccine that would be loaded with a patient's own souped up dendritic cells, which have been galvanized in gathering other cells of the immune system for fighting the virus, which is unique to that individual.

At the XVI International AIDS Conference (AIDS 2006), University of Pittsburgh researchers will describe one of the steps that is key to the approach's success – modifying the dendritic cells in such a way that they will get the attention of killer T cells. Results of these studies will be incorporated into the protocol for a clinical trial of the vaccine, which is expected to begin later this year.

“The goal of the approach is to teach killer T cells to more efficiently find, detect and destroy HIV infected cells. Our vaccine, as an immunotherapy, is custom-designed to target the unique virus that has evolved in each individual being treated. A patient's own dendritic cells together with their unique viral antigens comprise the main elements of the vaccine,” said Charles R. Rinaldo, Jr., Ph.D., professor and chairman of the department of infectious diseases and microbiology at Pitt's Graduate School of Public Health (GSPH) and the study's senior author.

In particular, the approach aims to activate a type of T cell called a CD8, or cytotoxic, T cell, also known as a killer T cell. In a typical immune response, CD8 cells are called to action by dendritic cells. Person
'"/>




Page: 1 2 3

Related medicine news :

1. Activated charcoal for poisoning treatment
2. Distinct Brain Sections Are Activated While Making Risky Decisions
3. Scientists Identify Genes Activated During Learning and Memory
4. Lean Protein Could Be Key to Obesity Drugs
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Nasal Spray Could Take Drugs Directly to Brain
7. Oxygen Usage During Exercise Could Indicate Heart Problems
8. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
9. Anger Could Be Linked To Weight Gain
10. A Seizure Late In Life Could be A Stroke Warning
11. New Findings Could Reduce The Extent Of Spinal Cord Injuries
Post Your Comments:
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Dental tourism is a phenomenon that was started by people that were looking for an alternative to the high price of dental work in the US, Canada, and other countries. In their search for lower priced
(Date:12/4/2009)Move a response to pressure from federal regulators to crack down on abuse of opioid medications , , FRIDAY, Dec. 4 (HealthDay News) -- The makers of 24 different prescription painkillers on F
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2
...er company says impact is ,significant and substan...lutant legislation, NEWARK, N.J., July 29 Eric S...th and safety, testified today before,Congress abo...known as CAIR). CAIR would have resulted in dramat...
...ticipants and spectators are reminded to protect t...rays on and off the field, PINELLAS PARK, Fla., J...gerly awaited time to enjoy outdoor sports and act...he summer,-- are conscious of the need to use sunb...
...A, Calif., July 29 On October 30, millions of bre... and loved ones will raise,their glasses in a "Toa... provides an opportunity for anyone,affected by br... cause advocates, thanking supporters, and showing...
...ferers Consider Veins a Cosmetic Issue Despite Exp... Discomfort, CHICAGO, July 29 Varicose veins -...y embarrassed sufferers to cover up, even on,the h...vey, many who suffer from varicose veins aren,t aw...
...Researchers at the University of Minnesota have fo...cognitive impairment in one of four child survivor...of the journal Pediatrics . , Malari...adliest forms of malaria. It only takes one bite f...
... RWSURVEY -- Web-Based Compliance Software Availab...unced the,release of its new web-based compliance ...w.rwsurvey.com ., The web-based software allows u...UA PCI HIPAA Compliance BSA-AML ISO 27001 Cob...
Other Medicine News:Health News:PSEG Supports Quick Congressional Action on Clean Air in Wake of Court's Rescinding of CAIR 2Health News:Transitions Optical Offers Tips on How to Protect Eyes for Outdoor Sports Fans 2Health News:Video: A 'Toast to the Cure' Set for October 30 Breast Cancer Survivors 'Raise Your Glasses' 2Health News:Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment 2Health News:Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment 3Health News:Survey Shows People With Varicose Veins Unaware of Health Risks; Most Never Consider Treatment 4Health News:U of M researchers find cerebral malaria may be a major cause of brain injury in African children 2Health News:New Web-Based Compliance Program Released by RiskWatch 2
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
(Date:12/3/2009)DURHAM, N.C., Dec. 3 In response to the increasingly critical role of healthcare information technologies in the evolving healthcare delivery system, Duke Medicine has created the Duke Center for Hea
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Surgeon Approved Pro Athlete Chiropractor Breaks the 2450 Billion Neck Pain Cycle With Launch of Pillo1 First Eco Luxe Neck Pillow 61153 1Surgeon Approved Pro Athlete Chiropractor Breaks the 2450 Billion Neck Pain Cycle With Launch of Pillo1 First Eco Luxe Neck Pillow 61153 2MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 1MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 2MinuteClinic Celebrates National Nurse Practitioner Week and Recognizes Role of Practitioners in Helping To Close Primary Care Gap 61151 3China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 1China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 2China Sky One Medical Inc Announces Conference Call to Discuss Third Quarter 2009 Results 14794 3
...ternational Conference of the American ... Forest Laboratories, Inc. and,Laboratorios Almir...al,trials assessing the efficacy and safety of acl...chronic obstructive pulmonary disease (COPD).,Data...the properties of,aclidinium were also presented a...
...ine and Synta,Pharmaceuticals Corp. (Nasdaq: SNTA... for elesclomol (formerly STA-4783), an investigat...c melanoma. A retrospective analysis,showed that s...elesclomol,and paclitaxel who had not previously r...nt improvement in progression-free survival (PFS),...
Other Medicine Technology:Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 2Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 3Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 4Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 5Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 6Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma 7
MedLook 3.0
... Manager and Collections Administrator has a maxim...billing models and personalized paper or electroni...ty to facilitate rebilling, ledger notes, follow-u...en Collections Worksheet and efficient collection ...
...ware Associates medical billing and practice manag...ronically, while providing your practice with acco...e interface allows you to see insurance payments, ...ntage of services rendered. You can break these nu...
Infinity Amylase CNPG3 (Liquid)
Medicine Products: